192 related articles for article (PubMed ID: 33815458)
1. Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis.
Hong C; Yang S; Wang Q; Zhang S; Wu W; Chen J; Zhong D; Li M; Li L; Li J; Yu H; Chen H; Zeng Q; Zhang C
Front Genet; 2021; 12():563051. PubMed ID: 33815458
[No Abstract] [Full Text] [Related]
2. Epigenetic age acceleration of cervical squamous cell carcinoma converged to human papillomavirus 16/18 expression, immunoactivation, and favourable prognosis.
Lu X; Zhou Y; Meng J; Jiang L; Gao J; Fan X; Chen Y; Cheng Y; Wang Y; Zhang B; Yan H; Yan F
Clin Epigenetics; 2020 Feb; 12(1):23. PubMed ID: 32041662
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic age acceleration of early stage hepatocellular carcinoma tightly associated with hepatitis B virus load, immunoactivation, and improved survival.
Fan X; Yuan H; Zhao S; Yang X; Shi R; Wang J; Zhao H
Cancer Biol Ther; 2020 Oct; 21(10):899-906. PubMed ID: 32914683
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer.
Koka H; Bodelon C; Horvath S; Lee PMY; Wang D; Song L; Zhang T; Hurson AN; Guida JL; Zhu B; Bailey-Whyte M; Wang F; Wu C; Tsang KH; Tsoi YK; Chan WC; Law SH; Hung RKW; Tse GM; Yuen KK; Karlins E; Jones K; Vogt A; Zhu B; Hutchinson A; Hicks B; Garcia-Closas M; Chanock S; Barnholtz-Sloan J; Tse LA; Yang XR
Clin Epigenetics; 2023 Mar; 15(1):55. PubMed ID: 36991516
[TBL] [Abstract][Full Text] [Related]
5. Estimating breast tissue-specific DNA methylation age using next-generation sequencing data.
Castle JR; Lin N; Liu J; Storniolo AMV; Shendre A; Hou L; Horvath S; Liu Y; Wang C; He C
Clin Epigenetics; 2020 Mar; 12(1):45. PubMed ID: 32164769
[TBL] [Abstract][Full Text] [Related]
6. Identification of the key genes controlling stomach adenocarcinoma stem cell characteristics via an analysis of stemness indices.
Wang G; Wu Z; Huang Y; Li Y; Bai Y; Luo Z; Huang W; Chen Z
J Gastrointest Oncol; 2022 Apr; 13(2):593-604. PubMed ID: 35557559
[TBL] [Abstract][Full Text] [Related]
7. Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis.
Zhang K; Wang J; Zhu Y; Liu X; Li J; Shi Z; Cao M; Li Y
Front Oncol; 2022; 12():844990. PubMed ID: 35686089
[TBL] [Abstract][Full Text] [Related]
8. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
9. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
11. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
12. High ADAMTS18 expression is associated with poor prognosis in stomach adenocarcinoma.
Jiang K; Li L; Xie Y; Xie D; Xiao Q
Oncol Lett; 2020 Nov; 20(5):211. PubMed ID: 32963617
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index.
Guo SH; Ma L; Chen J
J Oncol; 2022; 2022():8926127. PubMed ID: 36213825
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers.
Cuadros M; Cano C; Garcia-Rodriguez S; Martín JL; Poyatos-Andujar A; Ruiz-Cabello F; Pedrinaci S; Durán G; Benavides M; Bautista-Ojeda MD; Pereda T; Benitez-Cantos MS; Medina P; Blanco A; Gonzalez A; Lizardi P
BMC Med Genomics; 2022 Mar; 15(1):45. PubMed ID: 35246124
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma.
Pi Y; Zhan Y; Song J; Jin X; Chen J
J Gastrointest Oncol; 2022 Aug; 13(4):1589-1604. PubMed ID: 36092347
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.
Luo N; Fu M; Zhang Y; Li X; Zhu W; Yang F; Chen Z; Mei Q; Peng X; Shen L; Zhang Y; Li Q; Hu G
Front Cell Dev Biol; 2022; 10():935135. PubMed ID: 35859893
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
18. Decelerated DNA methylation age predicts poor prognosis of breast cancer.
Ren JT; Wang MX; Su Y; Tang LY; Ren ZF
BMC Cancer; 2018 Oct; 18(1):989. PubMed ID: 30333003
[TBL] [Abstract][Full Text] [Related]
19. Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma.
Wu B; Fu L; Guo X; Hu H; Li Y; Shi Y; Zhang Y; Han S; Lv C; Tian Y
Front Immunol; 2023; 14():984816. PubMed ID: 36761750
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation Age Drift Is Associated with Poor Outcomes and De-Differentiation in Papillary and Follicular Thyroid Carcinomas.
Liu T; Wang J; Xiu Y; Wu Y; Xu D
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
